I. Funke

4.2k total citations
35 papers, 3.4k citations indexed

About

I. Funke is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, I. Funke has authored 35 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 10 papers in Molecular Biology and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in I. Funke's work include Cancer Cells and Metastasis (11 papers), Glycosylation and Glycoproteins Research (6 papers) and Cell Adhesion Molecules Research (5 papers). I. Funke is often cited by papers focused on Cancer Cells and Metastasis (11 papers), Glycosylation and Glycoproteins Research (6 papers) and Cell Adhesion Molecules Research (5 papers). I. Funke collaborates with scholars based in Germany, Croatia and Netherlands. I. Funke's co-authors include G. Riethmüller, Günter Schlimok, Klaus Pantel, M. M. Heiss, F. W. Schildberg, K. W. Jauch, W. Schraut, Jens Witte, G. Eric Schaller and D Kutter and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Nature Medicine.

In The Last Decade

I. Funke

35 papers receiving 3.3k citations

Peers

Countries citing papers authored by I. Funke

Since Specialization

Citations

This map shows the geographic impact of I. Funke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I. Funke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I. Funke more than expected).

Fields of papers citing papers by I. Funke

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by I. Funke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I. Funke. The network helps show where I. Funke may publish in the future.

Co-authorship network of co-authors of I. Funke

This figure shows the co-authorship network connecting the top 25 collaborators of I. Funke. A scholar is included among the top collaborators of I. Funke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with I. Funke. I. Funke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Would it be safe to have a dog in the MRI scanner before your own examination? A multicenter study to establish hygiene facts related to dogs and men 2018 ·European Radiology ·Andreas Gutzeit, Frank Steffen, (unknown), (unknown), Sebastian Kos, (unknown), Livia Berlinger, (unknown), Carolin Reischauer, I. Funke, Johannes M. Froehlich, Dow‐Mu Koh, Christina Orasch	1
2	Prospective cohort study using the breast cancer spheroid model as a predictor for response to neoadjuvant therapy – the SpheroNEO study 2015 ·BMC Cancer ·Kathrin Halfter, Nina Ditsch, Hans‐Christian Kolberg, (unknown), (unknown), Franz Edler von Koch, Ingo Bauerfeind, Gϋnter von Minckwitz, I. Funke, Alexander Crispin, Barbara Mayer, (unknown)	30
3	Lysis of cancer cells by autologous T cells in breast cancer pleural effusates treated with anti-EpCAM BiTE antibody MT110 2008 ·Breast Cancer Research and Treatment ·(unknown), Bernd Schlereth, Klaus Brischwein, H. Winter, I. Funke, Karl‐Walter Jauch, Patrick A. Baeuerle, Barbara Mayer	16
4	Estrogen Receptor Expression Profile of Disseminated Epithelial Tumor Cells in Bone Marrow of Breast Cancer Patients 2003 ·Recent results in cancer research ·Nina Ditsch, Barbara Mayer, (unknown), Michael Untch, F. W. Schildberg, I. Funke	22
5	MHC class I negative phenotype of disseminated tumor cells in bone marrow is associated with poor survival in R0M0 breast cancer patients 2001 ·International Journal of Cancer ·(unknown), F. W. Schildberg, I. Funke	28
6	Meta-analyses of studies on bone marrow micrometastases: an independent prognostic impact remains to be substantiated. 1998 ·Journal of Clinical Oncology ·I. Funke, W. Schraut	168
7	De novo expression of the cell adhesion molecule E-selectin on gastric cancer endothelium 1998 ·Langenbeck s Archives of Surgery ·Barbara Mayer, Hanno Spatz, I. Funke, (unknown), F. W. Schildberg	17
8	Monoclonal antibody therapy for resected Dukes' C colorectal cancer: seven-year outcome of a multicenter randomized trial. 1998 ·Journal of Clinical Oncology ·G. Riethmüller, E Holz, Günter Schlimok, Wolff Schmiegel, R. Raab, K. Höffken, Rudolf Gruber, I. Funke, H. Pichlmaier, H. Hirche, Peter Buggisch, Jens Witte, R. Pichlmayr	407
9	The Rhesus D-negative phenotype is an independent predictor of poor prognosis in curatively (RO) resected gastric cancer patients 1997 ·British Journal of Cancer ·Barbara Mayer, W. Schraut, I. Funke, K.‐W. Jauch, W Mempel, J. P. Johnson, F. W. Schildberg	2
10	High expression of a Lewis(x)-related epitope in gastric carcinomas indicates metastatic potential and poor prognosis 1996 ·Gastroenterology ·Barbara Mayer, I. Funke, J. P. Johnson	18
11	Individual development and uPA–receptor expression of disseminated tumour cells in bone marrow: A reference to early systemic disease in solid cancer 1995 ·Nature Medicine ·M. M. Heiss, Heike Allgayer, Klaus Uwe Gruetzner, I. Funke, R. Babic, Karl‐Walter Jauch, F. W. Schildberg	207
12	Mikrometastasen im Knochenmark von Patienten mit Karzinomen des Kopf-Hals-Bereiches ^,* 1994 ·Laryngo-Rhino-Otologie ·Barbara Wollenberg, (unknown), (unknown), I. Funke, E. Wilmes	35
13	Subcutaneous IL-2 and Low-Dose IFN-α2a in the Treatment of Unselected Patients with Advanced Renal Cell Cancer 1994 ·Oncology Research and Treatment ·I. Funke, E. Späth‐Schwalbe, (unknown), Otto Prümmer, (unknown), Hubert Schrezenmeier, Franz Porzsolt	4
14	De-novo expression of CD44 and survival in gastric cancer 1993 ·The Lancet ·Barbara Mayer, K. W. Jauch, F. W. Schildberg, I. Funke, Ursula Günthert, Carl G. Figdor, J. P. Johnson	211
15	Differential Expression of Proliferation-Associated Molecules in Individual Micrometastatic Carcinoma Cells 1993 ·JNCI Journal of the National Cancer Institute ·Klaus Pantel, Günter Schlimok, Stephan Braun, D Kutter, Fritz Lindemann, G. Eric Schaller, I. Funke, Jakob R. Izbicki, G. Riethmüller	417
16	Expression of the CD6 T lymphocyte differentiation antigen in normal human brain 1990 ·Journal of Neuroimmunology ·Barbara Mayer, I. Funke, Brian Seed, G. Riethmüller, Elisabeth H. Weiss	28
17	Epithelial tumor cells in bone marrow of patients with colorectal cancer: immunocytochemical detection, phenotypic characterization, and prognostic significance. 1990 ·Journal of Clinical Oncology ·Günter Schlimok, I. Funke, Barbara C. Böck, (unknown), Jens Witte, G. Riethmüller	160
18	Glycoprotein P3.58, associated with tumor progression in malignant melanoma, is a novel leukocyte activation antigen 1988 ·International Journal of Cancer ·Bernhard Holzmann, J�rgen Lehmann, H.W.L. Ziegler-Heitbrock, I. Funke, G. Riethmüller, J. P. Johnson	39
19	The cellular receptor (CD4) of the human immunodeficiency virus is expressed on neurons and glial cells in human brain. 1987 ·The Journal of Experimental Medicine ·I. Funke, Amy B. Hahn, E. Peter Rieber, Elisabeth H. Weiss, G. Riethmüller	99
20	Monoclonal antibodies against human astrocytomas and their reactivity pattern 1987 ·Journal of the Neurological Sciences ·D Stavrou, E. Keiditsch, (unknown), K. Bise, I. Funke, Wolfgang Eisenmenger, R. Kurrle, (unknown), (unknown)	23

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact